Ophthalmology · Bronx, NY
NPI
1114000635
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
Mmc - Dept. of Ophthalmology, 3400 Bainbridge Avenue
Bronx, NY, 10467
Phone (718) 920-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
686 services
Medicare patients, 2024
224
Average age 74
Drug cost, 2024
$3.6M
10,569 prescriptions
Company payments, 2025
$2,092
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John J Kim was code 92136 (ultrasound - nonspecific), 82 times for 51 patients. In total John J Kim billed 686 services in 32 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92136 Ultrasound - Nonspecific | Office | 82 | 51 | $25.73 | $2,110 |
| 92014 Ophthalmological E&M | Office | 74 | 72 | $100.73 | $7,454 |
| 99213 Office E&M - Established | Office | 72 | 63 | $73.38 | $5,283 |
| 92133 Computerized Ophthalmic Imaging | Office | 70 | 68 | $28.89 | $2,022 |
| 66984 Cataract Surgery | Facility | 67 | 57 | $485.06 | $32K |
| 92202 Ophthalmological E&M | Office | 50 | 50 | $12.49 | $625 |
| 92134 Computerized Ophthalmic Imaging | Office | 40 | 39 | $35.65 | $1,426 |
| 92012 Ophthalmological E&M | Office | 38 | 38 | $61.95 | $2,354 |
| 92083 Vision, Hearing, and Speech Services | Office | 35 | 35 | $53.18 | $1,861 |
| 92250 Angiography | Office | 34 | 34 | $27.43 | $933 |
| 99214 Office E&M - Established | Office | 28 | 27 | $110.83 | $3,103 |
| 99204 Office E&M - New | Office | 19 | 19 | $153.49 | $2,916 |
| 99212 Office E&M - Established | Office | 13 | 13 | $44.68 | $581 |
| 92004 Ophthalmological E&M | Office | 11 | 11 | $124.02 | $1,364 |
By year: 2022 $135K for 1,284 services; 2023 $128K for 1,193 services; 2024 $80K for 686 services.
Medicare prescription drug claims, 2024
In 2024, the drug John J Kim prescribed most often to Medicare patients was Latanoprost, with 2,160 prescriptions and refills. In total John J Kim wrote 10,569 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,160 | 4,920 | 731 | $25K |
| Lumigan Bimatoprost | 1,250 | 2,457 | 379 | $699K |
| Restasis Cyclosporine | 924 | 1,703 | 260 | $1.0M |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 735 | 1,432 | 212 | $12K |
| Prednisolone Acetate Generic | 608 | 715 | 431 | $21K |
| Xiidra Lifitegrast | 600 | 1,191 | 200 | $781K |
| Combigan Brimonidine Tartrate/Timolol | 571 | 1,058 | 162 | $233K |
| Azelastine Hcl Generic | 531 | 882 | 170 | $7,892 |
| Timolol Maleate Generic | 504 | 1,031 | 151 | $10K |
| Brimonidine Tartrate Generic | 462 | 808 | 128 | $66K |
| Ofloxacin Generic | 295 | 307 | 263 | $4,227 |
| Ketorolac Tromethamine Generic | 287 | 314 | 233 | $5,095 |
| Miebo Perfluorohexyloctane/Pf | 254 | 311 | 84 | $227K |
| Rhopressa Netarsudil Mesylate | 252 | 404 | 70 | $135K |
| Dorzolamide Hcl Generic | 211 | 372 | 61 | $4,530 |
Brand drugs: 5,781 claims; generic drugs: 4,788 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John J Kim $2,092 ($2,092 in general payments such as food, travel and fees) from 13 companies. The largest payer was Alcon Vision LLC with $667.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 29 | $667 |
| Bausch & Lomb Americas Inc. BLCO | 6 | $369 |
| Oyster Point Pharma, Inc. | 7 | $196 |
| Abbvie Inc. ABBV | 11 | $193 |
| Mallinckrodt Hospital Products Inc. | 4 | $176 |
| Aerin Medical Inc. | 1 | $148 |
| Sight Sciences, Inc. SGHT | 1 | $125 |
| Amgen Inc. AMGN | 2 | $56.92 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $49.91 |
| Biotissue Holdings Inc. | 2 | $45.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.